Semaglutide is a proven, FDA-approved GLP-1 agonist for weight loss (1520% body weight reduction in clinical trials) Tirzepatide is a dual GIP/GLP-1 agonist showing up to 22% weight loss in trials often more potent than Semaglutide for some patients Retatrutide is an experimental triple agonist with promising early results, but is NOT FDA-approved and not yet available at Better Med Spa All three require medical supervision, lifestyle changes, and ongoing monitoring for safe, sustainable results Better Med Spa in Lincoln Park currently offers Semaglutide and Tirzepatide with physician-directed protocols, slow titration, and holistic wellness integration Quick Comparison: Semaglutide vs
Our providers are here to help you make progress that feels sustainable, not overwhelming, so you can take control of your health
Journal : Journal oo Nutrition Year : 2009 DOI : Increased levels oo plasma acylcarnitines in obesity and type 2 diabetes Mihalik, S.J., Goodpaster, B.H., Kelley, D.E., et al
Kidney and Liver Function : The kidneys and liver metabolise and excrete glutathione